Christopher H. Yaen

Array ( [id] => 5010826 [patent_doc_number] => 20070281305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Detection of lymph node metastasis from gastric carcinoma' [patent_app_type] => utility [patent_app_number] => 11/447255 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4422 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281305.pdf [firstpage_image] =>[orig_patent_app_number] => 11447255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 150802 [patent_doc_number] => 07682609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-23 [patent_title] => 'Protein formulation' [patent_app_type] => utility [patent_app_number] => 11/441994 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 17420 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/682/07682609.pdf [firstpage_image] =>[orig_patent_app_number] => 11441994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314965 [patent_doc_number] => 07524935 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Sequences characteristic of hypoxia-regulated gene transcription' [patent_app_type] => utility [patent_app_number] => 11/440016 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31424 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524935.pdf [firstpage_image] =>[orig_patent_app_number] => 11440016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263773 [patent_doc_number] => 07569538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Immunization of an individual against carcinomas and the preliminary stages thereof' [patent_app_type] => utility [patent_app_number] => 11/433386 [patent_app_country] => US [patent_app_date] => 2006-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1964 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569538.pdf [firstpage_image] =>[orig_patent_app_number] => 11433386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5682577 [patent_doc_number] => 20060198847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/416492 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29759 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20060198847.pdf [firstpage_image] =>[orig_patent_app_number] => 11416492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92510 [patent_doc_number] => 07732564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Serum tumor marker in rodent prostate cancer models' [patent_app_type] => utility [patent_app_number] => 11/412869 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7947 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732564.pdf [firstpage_image] =>[orig_patent_app_number] => 11412869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326775 [patent_doc_number] => 07514546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Antibodies' [patent_app_type] => utility [patent_app_number] => 11/333859 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 27 [patent_no_of_words] => 27277 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514546.pdf [firstpage_image] =>[orig_patent_app_number] => 11333859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705682 [patent_doc_number] => 20060194730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Tumor associated antigen peptides and use of same as anti-tumor vaccines' [patent_app_type] => utility [patent_app_number] => 11/391476 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 20814 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194730.pdf [firstpage_image] =>[orig_patent_app_number] => 11391476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874267 [patent_doc_number] => 20060166294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Apoptosis marker antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 11/388885 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18789 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166294.pdf [firstpage_image] =>[orig_patent_app_number] => 11388885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759627 [patent_doc_number] => 20060210572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Treatment of lymphatic metastatic cancerous lesions' [patent_app_type] => utility [patent_app_number] => 11/377186 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5487 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210572.pdf [firstpage_image] =>[orig_patent_app_number] => 11377186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700623 [patent_doc_number] => 20060217308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Compositions for the treatment of tumor pathologies, comprising internalin B (ln1B) of Listeria monocytogene protein or a fragment thereof' [patent_app_type] => utility [patent_app_number] => 11/372462 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10245 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217308.pdf [firstpage_image] =>[orig_patent_app_number] => 11372462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699552 [patent_doc_number] => 20060216236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Methods of inhibiting alphavBeta3-mediated angiogenesis and tumor development' [patent_app_type] => utility [patent_app_number] => 11/371620 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23773 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216236.pdf [firstpage_image] =>[orig_patent_app_number] => 11371620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759625 [patent_doc_number] => 20060210570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Methods and compositions for modulating prostasin' [patent_app_type] => utility [patent_app_number] => 11/359865 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 45267 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210570.pdf [firstpage_image] =>[orig_patent_app_number] => 11359865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859623 [patent_doc_number] => 20080268473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Adamts-7 as a Biomarker for Cancers of Epithelial Origin' [patent_app_type] => utility [patent_app_number] => 11/815821 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8022 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20080268473.pdf [firstpage_image] =>[orig_patent_app_number] => 11815821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263907 [patent_doc_number] => 07569672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Antibodies that bind to EphA2 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/349327 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27328 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569672.pdf [firstpage_image] =>[orig_patent_app_number] => 11349327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843284 [patent_doc_number] => 20060121526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression' [patent_app_type] => utility [patent_app_number] => 11/341515 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12651 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121526.pdf [firstpage_image] =>[orig_patent_app_number] => 11341515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672525 [patent_doc_number] => 20060177880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Use of PRN3/ILEU as a marker for colorectal cancer' [patent_app_type] => utility [patent_app_number] => 11/336707 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9279 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177880.pdf [firstpage_image] =>[orig_patent_app_number] => 11336707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322717 [patent_doc_number] => 07517950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Tumor antigen based on products of the tumor suppressor gene WT1' [patent_app_type] => utility [patent_app_number] => 11/322245 [patent_app_country] => US [patent_app_date] => 2006-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 4960 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517950.pdf [firstpage_image] =>[orig_patent_app_number] => 11322245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676133 [patent_doc_number] => 20080213763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Human Protooncogene and Protein Encoded by Same, and Expression Vector Containing Same' [patent_app_type] => utility [patent_app_number] => 11/794272 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23681 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213763.pdf [firstpage_image] =>[orig_patent_app_number] => 11794272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954506 [patent_doc_number] => 20080187530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Novel Agents and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/793708 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23452 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187530.pdf [firstpage_image] =>[orig_patent_app_number] => 11793708 [rel_patent_id] =>[rel_patent_doc_number] =>)